Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dvora Nelson

Surgery North Olmsted, OH Medical Doctor

NPI 1821098187 CMS profile 173053

30915 Lorain Rd, Suite 100, North Olmsted, OH 44070

Open in the dashboard

General payments

$108,254

158 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$12,243 paid to institutions, not to them · program year 2024

Through program year 2025, Dvora Nelson of North Olmsted, OH is reported in the CMS Open Payments database as having received $108,254 across 158 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $12,243 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,896 16
2024 General $20,537 29
2023 General $6,520 11
2022 General $14,879 28
2021 General $14,785 13
2020 General $14,729 11
2019 General $32,907 50

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dvora Nelson
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Dvora Nelson were reported at $3,896. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Dvora Nelson Surgery median Middle half National median
2019 $32,907 $253 $82–$1,521 $163
2020 $14,729 $131 $40–$706 $114
2021 $14,785 $168 $50–$904 $132
2022 $14,879 $224 $76–$1,218 $149
2023 $6,520 $253 $82–$1,255 $160
2024 $20,537 $279 $90–$1,381 $164
2025 $3,896 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $60,381 86 payments
  2. Medtronic Vascular, Inc. $47,328 56 payments
  3. Biocompatibles, Inc. $155 2 payments
  4. TherapeuticsMD, Inc. $121 1 payment
  5. Cashflow Solutions, LLC $68 4 payments
  6. Reapplix Inc. $67 1 payment
  7. Boston Scientific Corporation $32 2 payments
  8. Tactile Systems Technology Inc $32 2 payments
  9. Novo Nordisk Inc $24 1 payment
  10. Misonix Inc $18 1 payment
  11. Other $28 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $95,850 33 payments
  2. Travel and Lodging $4,793 24 payments
  3. Food and Beverage $4,079 99 payments
  4. Consulting Fee $3,531 2 payments
Products named General payments · program years 2019–2025
  1. ClosureFast EndoVenous Therapies $42,243 47 payments
  2. VENASEAL EndoVenous Therapies $34,724 61 payments
  3. ClosureFast EndoVenous Therapies $23,337 18 payments
  4. VenaSeal EndoVenous Therapies $5,086 9 payments
  5. VenaSeal EndoVenous Therapies $2,141 4 payments
  6. INTERSTIM $179 3 payments
  7. VARITHENA $155 2 payments
  8. IMVEXXY $121 1 payment
  9. PCD-52 737A (US) White $68 4 payments
  10. Lympha Press Optimal Plus(US) BT $68 4 payments
  11. Other $282 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

63

Median for General Surgery: 59

Drug cost

$55

Median for General Surgery: $393

Branded share of claims

0%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diazepam Generic 63 $55

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 15 billing codes

Paid by Medicare

$216,971

Medicare's payments for the services billed

Medicare patients

209

Average age 73

Services billed

1,047

173 women, 36 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 60%
Arthritis 55%
Osteoporosis 19%
Diabetes 18%
Cancer 18%
Ischemic heart disease 17%
COPD 14%
Chronic kidney disease 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

158 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record